Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering

Journal of Biomaterials Applications

Volumn 28, Issue 2, 2013, Pages 250-261

  Adwan, Hussamuddin ^a   Fuller, Barry ^a   Seldon, Clare ^a   Davidson, Brian ^a   Seifalian, Alexander ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

hepatocytes; HepG2; nanocomposite polymers; porogens; POSS modified polycaprolactone urea urethane; scaffolds; tissue engineering

Indexed keywords

HEPATOCYTES; HEPG2; NANOCOMPOSITE POLYMERS; POROGENS; POSS-MODIFIED POLYCAPROLACTONE UREA URETHANE;

CELL CULTURE; CELLS; ESTERS; EXPERIMENTS; GLUCOSE; METABOLISM; MORPHOLOGY; NANOCOMPOSITES; PATIENT REHABILITATION; POLYMERS; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING; UREA;

SCAFFOLDS (BIOLOGY);

ALBUMIN; ASPARTATE AMINOTRANSFERASE; BICARBONATE; GLUCOSE; MOLECULAR SCAFFOLD; NANOCOMPOSITE; OLIGOMER; POLYCAPROLACTONE; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; POLYMER; POLYURETHAN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UREA;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; LIVER CELL; POROSITY; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

EID: 84881128491     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328212445404     Document Type: Article

References (52)

1. Facts about liver disease, http://www.britishlivertrust.org. uk/data/5/pages/2 aspx?pid=280 (2008). (accessed 31 January 2008).
2. Standards for solid organ transplantation in the United Kingdom, http://www.bts.org.uk/Forms/standards%20document%20edition%202%20-%20final pdf (2003 July). (accessed 31 January 2008).
3. Transplant activity in the UK, http://www.uktransplant. org.uk/ukt/statistics/transplant-activity-report/current-activity-reports/ukt/ transplant-activity-uk-2006-2007 pdf (2007 August). (accessed 31 January 2008).
4. Vienken J, Christmann H. How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial. 2006 ; 10 (2). 125-131
5. Laleman W, Wilmer A, Evenepoel P, et al. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther. 2006 ; 23 (3). 351-363
6. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol. 2005 ; 100 (2). 468-475
7. Rozga J. Liver support technology - an update. Xenotransplantation. 2006 ; 13 (5). 380-389
8. Mitzner S, Klammt S, Stange J, et al. Albumin regeneration in liver support-comparison of different methods. Ther Apher Dial. 2006 ; 10 (2). 108-117
9. Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut. 2004 ; 53 (6). 890-898
10. Pryor HI, Vacanti JP. The promise of artificial liver replacement. Front Biosci. 2008 ; 13: 2140-2159
11. Gerlach JC, Zeilinger K, Patzer Ii JF. Bioartificial liver systems: why, what, whither?. Regen Med. 2008 ; 3 (4). 575-595
12. Faenza S, Baraldi O, Bernardi M, et al. Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc. 2008 ; 40 (4). 1169-1171
13. Dethloff T, Tofteng F, Frederiksen HJ, et al. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol. 2008 ; 14 (13). 2065-2071
14. Fiegel HC, Havers J, Kneser U, et al. Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Eng. 2004 ; 10 (1-2). 165-174
15. Takashi H, Katsumi M, Toshihiro A. Hepatocytes maintain their function on basement membrane formed by epithelial cells. Biochem Biophys Res Commun. 2007 ; 359 (1). 151-156
16. Miyazawa M, Torii T, Toshimitsu Y, et al. Hepatocyte dynamics in a three-dimensional rotating bioreactor. J Gastroenterol Hepatol. 2007 ; 22 (11). 1959-1964
17. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007 ; 213 (2). 286-300
18. Kim SS, Utsunomiya H, Koski JA, et al. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg. 1998 ; 228 (1). 8-13
19. Allen JW, Bhatia SN. Engineering liver therapies for the future. Tissue Eng. 2002 ; 8 (5). 725-737
20. Fiegel HC, Kaufmann PM, Bruns H, et al. Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med. 2008 ; 12 (1). 56-66
21. Torok E, Pollok JM, Ma PX, et al. Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Dig Surg. 2001 ; 18 (3). 196-203
22. Sellaro TL, Ravindra AK, Stolz DB, et al. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 2007 ; 13 (9). 2301-2310
23. Zavan B, Brun P, Vindigni V, et al. Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies. Biomaterials. 2005 ; 26 (34). 7038-7045
24. Bruns H, Kneser U, Holzhuter S, et al. Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng. 2005 ; 11 (11-12). 1718-1726
25. Vienken J, Christmann H. How can liver toxins be removed? Filtration and adsorption with the Prometheus system. Ther Apher Dial. 2006 ; 10 (2). 125-131
26. Laleman W, Wilmer A, Evenepoel P, et al. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther. 2006 ; 23 (3). 351-363
27. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol. 2005 ; 100 (2). 468-475
28. Mitzner S, Klammt S, Stange J, et al. Albumin regeneration in liver support-comparison of different methods. Ther Apher Dial. 2006 ; 10 (2). 108-117
29. Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care. 2007 ; 13 (2). 215-221
30. Planchamp C, Vu TL, Mayer JM, et al. Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications. J Pharm Pharmacol. 2003 ; 55 (9). 1181-1198
31. Jasmund I, Bader A. Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. Adv Biochem Eng Biotechnol. 2002 ; 74: 99-109
32. Allen JW, Hassanein T, Bhatia SN. Advances in bioartificial liver devices. Hepatology. 2001 ; 34 (3). 447-455
33. Chamuleau RA. Artificial liver support in the third millennium. Artif Cells Blood Substit Immobil Biotechnol. 2003 ; 31 (2). 117-126
34. Hoque ME, Mao HQ, Ramakrishna S. Hybrid braided 3-D scaffold for bioartificial liver assist devices. J Biomater Sci Polym Ed. 2007 ; 18 (1). 45-58
35. Kaufmann PM, Heimrath S, Kim BS, et al. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes: initial results. Transplant Proc. 1997 ; 29 (4). 2032-2034
36. Kaufmann PM, Kneser U, Fiegel HC, et al. Long-term hepatocyte transplantation using three-dimensional matrices. Transplant Proc. 1999 ; 31 (4). 1928-1929
37. Kaufmann PM, Heimrath S, Kim BS, et al. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant. 1997 ; 6 (5). 463-468
38. Mooney DJ, Park S, Kaufmann PM, et al. Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res. 1995 ; 29 (8). 959-965
39. Uyama S, Kaufmann PM, Kneser U, et al. Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: comparison with heterotopically transplanted liver grafts. Transplantation. 2001 ; 71 (9). 1226-1231
40. Davis MW, Vacanti JP. Toward development of an implantable tissue engineered liver. Biomaterials. 1996 ; 17 (3). 365-372
41. Kulig KM, Vacanti JP. Hepatic tissue engineering. Transpl Immunol. 2004 ; 12 (3-4). 303-310
42. Madbouly SA, Otaigbe JU, Nanda AK, et al. Rheological behavior of POSS/polyurethane-urea nanocomposite films prepared by homogeneous solution polymerization in aqueous dispersions. Macromolecules. 2007 ; 40 (14). 4982-4991
43. Hule RA, Pochan D. Polymer Nanocomposites for biomedical applications. MRS Bulletin. 2007 ; 32: 354-358
44. Neumann D, Fisher M, Tran L, et al. Synthesis and characterization of an isocyanate functionalized polyhedral oligosilsesquioxane and the subsequent formation of an organic-inorganic hybrid polyurethane. J Am Chem Soc. 2002 ; 124 (47). 13998-13999
45. Kannan RY, Salacinski HJ, Ghanavi JE, et al. Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg. 2007 ; 119 (6). 1653-1662
46. Kannan RY, Salacinski HJ, Sales KM, et al. The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys. 2006 ; 45 (2). 129-136
47. Kannan RY, Salacinski HJ, Odlyha M, et al. The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials. 2006 ; 27 (9). 1971-1979
48. Alobaid N, Salacinski HJ, Sales KM, et al. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur J Vasc Endovasc Surg. 2006 ; 32 (1). 76-83
49. Goh YQ, Ooi CP. Fabrication and characterization of porous poly(L-lactide) scaffolds using solid-liquid phase separation. J Mater Sci Mater Med. 2008 ; 19 (6). 2445-2452
50. Yamashita Y, Shimada M, Tsujita E, et al. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant. 2001 ; 10 (8). 717-722
51. Petrie A, Sabin C Medical statistics at a glance. 2 nd ed. Malden, MA: Blackwell, 2005. Malden, MA: Blackwell ; 2005:
52. Harimoto N, Taketomi A, Kitagawa D, et al. The newly established human hepatocyte cell line: application for the bioartificial liver. J Hepatol. 2005 ; 42 (4). 557-564